MLXIPL and fatty liver disease: This study provides insight into the complex regulation of ChREBP isoforms in metabolic tissues, adds further evidence to the notion that hepatic steatosis is not a causal factor in the development of insulin resistance, and highlights a novel role for ChREBP in diet-induced inflammation in obesity.